Archive for March 2013
Emily Fritchey is a Holistic Skin Therapist and natural health practitioner whose cutting-edge approach to dramatic skin transformation has made her not only a respected trend-setter among her peers in the field of aesthetics and cosmetic surgery, but an award-winning product formulator and expert on botanical skin treatments. Preceding her many years in the aesthetics field was her own painful struggle with problem skin that conventional medicine could not resolve. This led to her to intense study in the field of cosmetic chemistry, nutrition, herbology and natural medicine that ultimately led not only to the solution and resolution of her chronic skin disorders, but to the development of her own results-oriented line of natural skincare products - Sunshine Botanicals. Her company was recently awarded the “Beauty with a Conscience” award from Natural Solutions Magazine for excellence in product formulation - for the third time. Her unique approach to product formulation has been published in beauty media, as well as major medical journals, including Cosmetic Surgery Times, and Dermatology Times - June and August 2008, respectively.www.sunshinebotanicals.com
Outliving Cancer: There Better, Smarter Way to Treat Cancer with Dr. Robert Nagourney
In addition to his position as medical and laboratory director at Rational Therapeutics, Robert A. Nagourney, MD, is an instructor of Pharmacology at the University of California, Irvine School of Medicine. He is board-certified in Internal Medicine, Medical Oncology and Hematology.
A native of Bridgeport, Connecticut, Dr. Nagourney completed his undergraduate education at Boston University, earning a BA in Chemistry, Summa Cum Laude, Phi Beta Kappa with Distinction in Biochemistry. He received his medical degree at McGill University in Montreal, Canada, where he was a University Scholar. After completing his residency in Internal Medicine at the University of California, Irvine, Dr. Nagourney received fellowship training in Medical Oncology at Georgetown University in Washington, DC. He went on to complete a second fellowship in Hematology at the Scripps Institute in La Jolla, California, where he was the recipient of the Scripps Institute Young Investigator Award.
In 1986, Dr. Nagourney co-founded Oncotech with Larry Weisenthal, MD, PhD. After serving as the medical director, he left Oncotech in 1991 to focus his full attention on the study of drug-induced programmed cell death in human tumor primary cultures. Recognizing the profound impact that these discoveries would have upon the practice of clinical oncology, he accepted the position of Director of Experimental Therapeutics at Long Beach Memorial in California. Convinced that the broad application of Ex Vivo Analysis had the potential to revolutionize patient care, Dr. Nagourney founded Rational Therapeutics in 1993, where he pioneered the use of "functional profiling" to create the world’s first personalized cancer therapy program.
Two fundamental breakthroughs underlie the success of Dr. Nagourney’s approach. The first was the recognition that cancer reflected a deregulation of cell survival, not cell proliferation. The second reflected an understanding of cancer biology as cancer ecology. Wherein, cancer cells must be studied in their native state, not propagated, sub-cultured nor removed from their stroma, inflammatory and vascular environment.
With more than 20 years experience in human tumor primary culture analyses, Dr. Nagourney has authored more than 100 manuscripts, book chapters and abstracts; including publications in the Journal of Clinical Oncology, Gynecological Oncology and The Journal of National Cancer Institute. As co-investigator on national cooperative trials, Dr. Nagourney is recognized for the introduction of cisplatin/Gemcitabine doublets in the treatment of advanced ovarian and breast cancers.
With the desire to change how cancer care is delivered, he accepted the position as Medical Director of the Todd Cancer Institute at Long Beach Memorial in 2003. In 2008, he returned to Rational Therapeutics full-time to rededicate his expertise to expanding the Rational Therapeutics program, nationally and internationally.
He is a frequently invited lecturer for numerous professional organizations and universities, and has served as a reviewer and on the editorial boards of several journals including Clinical Cancer Research, British Journal of Cancer, Gynecologic Oncology, Cancer Research and the Journal of Medicinal Food.
several leading cancer centers in Europe. Mr. Wainright has collaborated with the Institute for Laboratory Medicine in Recklinghausen, Germany on reversing DNA damage and improving gene expressions in cancer cells with soy phytochemicals. He has designed and completed clinical trials in Asia, Europe and the United States showing the human health benefits of dietary soy phytochemicals. His research and experience with humans documents the benefits of soy therapy for both the prevention and treatment of estrogen receptor positive breast, ovarian, prostate and other cancers. Mr. Wainrights’ research also addresses how the soy phytochemicals protect cancer patients from chemotherapy induced cell mutations, related toxicity, infections, leukopenia and anemia; it also enhances cancer cell killing effectiveness 8-10 times greater than chemotherapy treatments by themselves. His research has been the subject of several peer reviewed articles on killing treatment resistant cancer stem cells. Mr. Wainright is an internationally recognized lecturer. He has lectured at the Royal Society of Medicine in London, the European Society of Anti-Aging Medicine in Vienna, and other prestigious conferences in Europe, Brazil and North America.
What Women Must Know - Deep Truths from an Interventional Cardiologist with Dr. Joel Kahn - 03/10/13